Voriconazole-loaded self-nanoemulsifying drug delivery system (SNEDDS) to improve transcorneal permeability

References

• Adams AIH, Gosmann G, Schneider PH, Bergold AM. 2009. LC stability studies of voriconazole and structural elucidation of its major degradation product. Chroma. 69(S2):115–122.
   Google Scholar
• Al-Badriyeh D, Li J, Stewart K, Kong DCM, Leung L, Davies GE, Fullinfaw R. 2009. Stability of extemporaneously prepared voriconazole ophthalmic solution. Am J Health Syst Pharm. 66(16):1478–1483.
   PubMed Web of Science ®Google Scholar
• Andrade LM, Rocha KAD, De Sá FAP, Marreto RN, Lima EM, Gratieri T, Taveira SF. 2016. Voriconazole-loaded nanostructured lipid carriers for ocular drug delivery. Cornea. 35(6):866–871.
   PubMed Web of Science ®Google Scholar
• Bachu R, Chowdhury P, Al-Saedi Z, Karla P, Boddu S. 2018. Ocular drug delivery barriers role of nanocarriers in the treatment of anterior segment ocular diseases. Pharmaceutics. 10(1):28–31.
   Web of Science ®Google Scholar
• Bahloul B, Lassoued MA, Sfar S. 2014. A novel approach for the development and optimization of self emulsifying drug delivery system using HLB and response surface methodology: application to fenofibrate encapsulation. Int J Pharm. 466(1–2):341–348.
   PubMedGoogle Scholar
• Battaglia L, Serpe L, Foglietta F, Muntoni E, Gallarate M, Rodriguez ADP, Solinis MA. 2016. Application of lipid nanoparticles to ocular drug delivery. Expert Opin Drug Deliv. 13(12):1743–1757.
   PubMed Web of Science ®Google Scholar
• Beg S, Swain S, Rahman M, Hasnain MS, Imam SS. 2019. Chapter 3: application of design of experiments (DoE) in pharmaceutical product and process optimization. In: Beg S, Hasnain MS, editors. Pharmaceutical quality by design. London: Academic press; p. 43–64.
   Google Scholar
• Bhosale R, Bhandwalkar O, Duduskar A, Jadhav R, Pawar P. 2016. Water soluble chitosan mediated voriconazole microemulsion as sustained carrier for ophthalmic application: in vitro/ex vivo/in vivo evaluations. Open Pharm Sci J. 3(1):215–234.
   Google Scholar
• Chandasana H, Prasad YD, Chhonker YS, Chaitanya TK, Mishra NN, Mitra K, Shukla PK, Bhatta RS. 2014. Corneal targeted nanoparticles for sustained natamycin delivery and their PK/PD indices: an approach to reduce dose and dosing frequency. Int J Pharm. 477(1–2):317–325.
   PubMedGoogle Scholar
• Chaudhari KS, Akamanchi KG. 2019. Novel bicephalous heterolipid based self-microemulsifying drug delivery system for solubility and bioavailability enhancement of efavirenz. Int J Pharm. 560:205–218.
   PubMedGoogle Scholar
• Chen Y, Quan P, Liu X, Wang M, Fang L. 2014. Novel chemical permeation enhancers for transdermal drug delivery. Asian J Pharm Sci. 9(2):51–64.
   Google Scholar
• Cornell J.A. 2011. A primer on experiments with mixtures. New York (NY): Wiley.
   Google Scholar
• Cox DR. 1971. A note on polynomial response functions for mixtures. Biometrika. 58(1):155–159.
   Web of Science ®Google Scholar
• Craig DQM, Barker SA, Banning D, Booth SW. 1995. An investigation into the mechanisms of self-emulsification using particle size analysis and low frequency dielectric spectroscopy. Int J Pharm. 114(1):103–110.
   Web of Science ®Google Scholar
• Dalvadi H, Patel N, Parmar K. 2017. Systematic development of design of experiments (DoE) optimised self-microemulsifying drug delivery system of Zotepine. J Microencapsul. 34(3):308–318.
   PubMed Web of Science ®Google Scholar
• Danaei M, Dehghankhold M, Ataei S, Hasanzadeh DF, Javanmard R, Dokhani A, Khorasani S, Mozafari M. 2018. Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems. Pharmaceutics. 10(2):57.
   PubMed Web of Science ®Google Scholar
• De Sá FAP, Taveira SF, Gelfuso GM, Lima EM, Gratieri T. 2015. Liposomal voriconazole (VOR) formulation for improved ocular delivery. Colloids Surf B. 133:331–338.
   PubMed Web of Science ®Google Scholar
• Elrebii M, Kamoun A, Boufi S. 2015. Waterborne hybrid alkyd–acrylic dispersion: optimization of the composition using mixture experimental designs. Prog Org Coat. 87:222–231.
   Web of Science ®Google Scholar
• Engelbrecht TN, Demé B, Dobner B, Neubert R. 2012. Study of the influence of the penetration enhancer isopropyl myristate on the nanostructure of stratum corneum lipid model membranes using neutron diffraction and deuterium labelling. Skin Pharmacol Physiol. 25(4):200–207.
   PubMed Web of Science ®Google Scholar
• European Pharmacopoeia Commission. 2017. Methods of preparation of sterile products: method 5.1.1. 50101. In: European pharmacopoeia. 9th ed. Strasbourg: European Directorate for the Quality of Medicines (EDQM).
   Google Scholar
• Fanun M. 2010. Chapter 10: Microemulsion system: application in delivery of poorly soluble drugs. In: Fanun M, editors. Colloids in drug delivery. New York: Taylor and Francis; p. 245–265.
   Google Scholar
• Ghadiri M, Fatemi S, Vatanara A, Doroud D, Najafabadi AR, Darabi M, Rahimi AA. 2012. Loading hydrophilic drug in solid lipid media as nanoparticles: statistical modeling of entrapment efficiency and particle size. Int J Pharm. 424(1–2):128–137.
   PubMed Web of Science ®Google Scholar
• Goupy J, Creighton L. 2006. Introduction aux plans d’expériences [Introduction to design of experiments]. 3rd ed. Paris (France): Dunod/L’usine nouvelle.
   Google Scholar
• Hariprasad SM, Mieler WF, Lin TK, Sponsel WE, Graybill JR. 2008. Voriconazole in the treatment of fungal eye infections: a review of current literature. Br J Ophthalmol. 92(7):871–878.
   PubMed Web of Science ®Google Scholar
• Harrington R, Lee E, Yang H, Wei J, Messali A, Azie N, Wu EQ, Spalding J. 2017. Cost-effectiveness analysis of isavuconazole vs. voriconazole as first-line treatment for invasive aspergillosis. Adv Ther. 34(1):207–220.
   PubMed Web of Science ®Google Scholar
• Hashemnejad SM, Badruddoza AZM, Zarket B, Castaneda CR, Doyle PS. 2019. Thermoresponsive nanoemulsion-based gel synthesized through a low-energy process. Nat Commun. 10(1):1–10.
   PubMedGoogle Scholar
• Heralgi MM, Badami A, Vokuda H, Venkatachalam K. 2016. An update on voriconazole in ophthalmology. DJO. 27(1):9–15.
   Google Scholar
• Ibrahim SS. 2019. The role of surface active agents in ophthalmic drug delivery: a comprehensive review. J Pharm Sci. 108 (6):1923–1933.
   PubMed Web of Science ®Google Scholar
• Jiao J. 2008. Polyoxyethylated nonionic surfactants and their applications in topical ocular drug delivery. Adv Drug Deliv Rev. 60(15):1663–1673.
   PubMed Web of Science ®Google Scholar
• Katara R, Sachdeva S, Majumdar DK. 2018. Aceclofenac oil drops: characterization and evaluation against ocular inflammation. Pharm Dev Technol. 23(3):240–246.
   PubMed Web of Science ®Google Scholar
• Kaur IP, Smitha R. 2002. Penetration enhancers and ocular bioadhesives: two new avenues for ophthalmic drug delivery. Drug Dev Ind Pharm. 28(4):353–369.
   PubMed Web of Science ®Google Scholar
• Khatri P, Shao J. 2018. Mechanism and structural factors of lipid and surfactant in the formation of self-emulsified nanoemulsion. J Pharm Sci. 107(8):2198–2207.
   PubMed Web of Science ®Google Scholar
• Kumar R, Sinha VR. 2014. Preparation and optimization of voriconazole microemulsion for ocular delivery. Colloids Surf. B. 117:82–88.
   PubMed Web of Science ®Google Scholar
• Kundu P, Arora K, Gu Y, Kumar V, Mishra I M. 2019. Formation and stability of water‐in‐oil nano‐emulsions with mixed surfactant using in‐situ combined condensation‐dispersion method. Can J Chem Eng. 97(7):2039–2049.
   Web of Science ®Google Scholar
• Kuo MT, Chen JL, Hsu SL, Chen A, You HL. 2019. An omics approach to diagnosing or investigating fungal keratitis. IJMS. 20(15):3631.
   Google Scholar
• Lamaallam S, Bataller H, Dicharry C, Lachaise J. 2005. Formation and stability of miniemulsions produced by dispersion of water/oil/surfactants concentrates in a large amount of water. Colloids Surf. A. 44:270–271.
   Google Scholar
• Lassoued MA, Sfar S, Bouraoui A, Khemiss F. 2012. Absorption enhancement studies of clopidogrel hydrogen sulphate in rat everted gut sacs. J Pharm Pharmacol. 64(4):541–552.
   PubMed Web of Science ®Google Scholar
• Lawson J, Willden C. 2016. Mixture experiments in R using mixexp. J Stat Softw. 72(1):1–20.
   Google Scholar
• Lefebvre G, Riou J, Bastiat G, Roger E, Frombach K, Gimel J-C, Saulnier P, Calvignac B. 2017. Spontaneous nano-emulsification: process optimization and modeling for the prediction of the nanoemulsion’s size and polydispersity. Int J Pharm. 534(1–2):220–228.
   PubMed Web of Science ®Google Scholar
• Maharana PK, Sharma N, Nagpal R, Jhanji V, Das S, Vajpayee RB. 2016. Recent advances in diagnosis and management of Mycotic keratitis. Indian J Ophthalmol. 64(5):346–357.
   PubMed Web of Science ®Google Scholar
• Mahmoudi S, Masoomi A, Ahmadikia K, Tabatabaei SA, Soleimani M, Rezaie S, Ghahvechian H, Banafsheafshan A. 2018. Fungal keratitis: an overview of clinical and laboratory aspects. Mycoses. 61(12):916–930.
   PubMed Web of Science ®Google Scholar
• Mathieu D, Phan-Tan-Luu R. 2001. Planification d’expériences en formulation: optimisation. Techniques de l’ingénieur. J. 2241:1–15.
   Google Scholar
• McClements DJ. 2012. Nanoemulsions versus microemulsions: terminology, differences, and similarities. Soft Matter. 8(6):1719–1729.
   Web of Science ®Google Scholar
• Monti D, Chetoni P, Burgalassi S, Najarro M, Saettone MF. 2002. Increased corneal hydration induced by potential ocular penetration enhancers: assessment by differential scanning calorimetry (DSC) and by desiccation. Int J Pharm. 232(1–2):139–147.
   PubMed Web of Science ®Google Scholar
• Moore JW, Flanner HH. 1996. Mathematical comparison of dissolution profiles. Pharm Technol. 20:64–74.
   Google Scholar
• Politis N, Colombo P, Colombo G, Rekkas M. 2017. Design of experiments (DoE) in pharmaceutical development. Drug Dev Ind Pharm. 43(6):889–901.
   PubMed Web of Science ®Google Scholar
• Prajna NV, Krishnan T, Rajaraman R, Patel S, Shah R, Srinivasan M, Devi L, Das M, Ray KJ, O’Brien KS, et al. 2017. Adjunctive oral voriconazole treatment of fusarium keratitis. JAMA Ophthalmol. 135(6):520–525.
   PubMed Web of Science ®Google Scholar
• Rais F, Jelidi A, Kamoun A, Chaabouni M, Sergent M, Phan-Tan-Luu R. 2004. Use of an ellipsoidal subregion of interest in the space of mixture components to the optimization of a fluoroanhydrite-based self-leveling floor composition. Chemom Intell Lab Syst. 74(2):253–261.
   Web of Science ®Google Scholar
• Sánchez-López E, Espina M, Doktorovova S, Souto EB, García ML. 2017. Lipid nanoparticles (SLN, NLC): overcoming the anatomical and physiological barriers of the eye – part I – barriers and determining factors in ocular delivery. Eur J Pharm Biopharm. 110:70–75.
   PubMed Web of Science ®Google Scholar
• Seyfoddin A, Al-Kassas R. 2013. Development of solid lipid nanoparticles and nanostructured lipid carriers for improving ocular delivery of acyclovir. Drug Dev Ind Pharm. 39(4):508–519.
   PubMed Web of Science ®Google Scholar
• Shafiq S, Shakeel F, Talegaonkar S, Ahmad FJ, Khar RK, Ali M. 2007. Development and bioavailability assessment of ramipril nanoemulsion formulation. Eur J Pharm Biopharm. 66(2):227–243.
   PubMed Web of Science ®Google Scholar
• Sharma D, Maheshwari D, Philip G, Rana R, Bhatia S, Singh M, Gabrani R, Sharma SK, Ali J, Sharma RK. 2014. Formulation and optimization of polymeric nanoparticles for intranasal delivery of lorazepam using box-Behnken Design: In Vitro and In Vivo evaluation. Biomed Res Int. 2014:1–14.
   Google Scholar
• Singh B, Bandopadhyay S, Kapil R, Singh R, Katare O. 2009. Self-emulsifying drug delivery systems (SEDDS): formulation development, characterization, and applications. Crit Rev Ther Drug Carrier Syst. 26(5):427–521.
   PubMed Web of Science ®Google Scholar
• Soni V, Pandey V, Tiwari R, Asati S, Tekade RK. 2019. Chapter 13: design and evaluation of ophthalmic delivery formulations. In: Fundamentals of drug delivery. London: Academic press; p. 473–538.
   Google Scholar
• Tauler R, Walczak B, Brown SD. 2009. Chapter 1.13: experimental design for mixture studies. In: Comprehensive chemometrics: chemical and biochemical data analysis. Slovenia, Elsevier; p. 391–449.
   Google Scholar
• Tayel SA, El-Nabarawi MA, Tadros MI, Abd E. 2013. Promising ion-sensitive in situ ocular nanoemulsion gels of terbinafine hydrochloride: design, in vitro characterization and in vivo estimation of the ocular irritation and drug pharmacokinetics in the aqueous humor of rabbits. Int J Pharm. 443(1–2):293–305.
   PubMed Web of Science ®Google Scholar
• Thomas PA, Kaliamurthy J. 2013. Mycotic keratitis: epidemiology, diagnosis and management. Clin. Microbiol Infect. 19(3):210–220.
   PubMed Web of Science ®Google Scholar
• Üstündağ O, Yozgatlı N, Okur V, Yoltaş ME, Siafaka A, Panoraia I. 2019. Improving therapeutic efficacy of voriconazole against fungal keratitis: thermo-sensitive in situ gels as ophthalmic drug carriers. J Drug Deliv Sci Technol. 49:323–333.
   Web of Science ®Google Scholar
• Vadlapudi AD, CholKAr K, Dasari SR, Mitra AK. 2015. Chapter 10: ocular drug delivery. In: Drug delivery. Burlington (MA): Jones & Bartlett; p. 219–263.
   Google Scholar
• Vining GG, Cornell JA, Myers RH. 1993. A graphical approach for evaluating mixture designs. J R Stat Soc Ser C Appl Stat. 42(1):127–138.
   Web of Science ®Google Scholar
• Wang L, Dong J, Chen J, Eastoe J, Li X. 2009. Design and optimization of a new self-nanoemulsifying drug delivery system. J Colloid Interface Sci. 330(2):443–448.
   PubMed Web of Science ®Google Scholar
• Washington N, Washington C, WIlson C. 2001. Chapter 11: ocular drug delivery. In: Physiological pharmaceutics: barriers to drug absorption. London, Taylors and Francis; p. 249–269.
   Google Scholar
• Wooster TJ, Labbett D, Sanguansri P, Andrews H. 2016. Impact of microemulsion inspired approaches on the formation and destabilisation mechanisms of triglyceride nanoemulsions. Soft Matter. 12(5):1425–1435.
   PubMed Web of Science ®Google Scholar